CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential.
about
Cooperation of ERK and SCFSkp2 for MKP-1 destruction provides a positive feedback regulation of proliferating signalingThe aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancersRole of DUSP1/MKP1 in tumorigenesis, tumor progression and therapyThe investigation of mitogen-activated protein kinase phosphatase-1 as a potential pharmacological target in non-small cell lung carcinomas, assisted by non-invasive molecular imagingAsparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines.Microarray phosphatome profiling of breast cancer patients unveils a complex phosphatase regulatory role of the MAPK and PI3K pathways in estrogen receptor-negative breast cancersTargeting the mitogen-activated protein kinase cascade to treat cancer.Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease.Targeting the ERK signaling pathway in cancer therapy.Diversity and specificity of the mitogen-activated protein kinase phosphatase-1 functions.Ovarian cancer molecular pathology.The regulatory roles of phosphatases in cancer.Anti-TNF effects on destructive fibroblasts depend on mechanical stress.Role of MAPK phosphatase-1 in the induction of monocyte chemoattractant protein-1 during the course of adipocyte hypertrophy.Formyl peptide receptor 2 expression predicts poor prognosis and promotes invasion and metastasis in epithelial ovarian cancer.High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response.The impact of phosphatases on proliferative and survival signaling in cancer.
P2860
Q50432263-AFE9876C-EE08-4FC0-88EA-613865495167Q54606453-DA9D4B77-22A6-4207-93DE-D193B4708553Q54606559-A3DF94AF-42BC-49A3-BF54-8F0D9619218FQ54606604-520155C4-D1A7-4072-BCE4-AF67CB9E61F8Q54606751-0C90A1A5-EBEB-4271-B388-97D146335485Q54606942-E216AF9C-BE3E-43E3-A066-4D9DA1A1E10EQ54808585-4F84153C-363F-45AA-9D19-F79B5AD3C74AQ54936983-36068E6D-0B34-4D8B-A335-D87C3ACD5A8CQ54937010-8A8852FA-E224-4FF5-A8EC-2796FF97C494Q54937038-13EDA127-269E-4183-BFF1-52DC8B2B03CAQ54989618-1C890E06-4753-42CC-A19A-AB65434614F9Q54989620-B0378A30-3077-4782-BCC9-1721B06F36C1
P1343
Q24294827-42F337B5-AE25-468F-A2D2-8A5CA40C1583Q24683145-BF6A064F-0DA3-499B-A34D-7C1BFF7E316BQ26745758-A12ABE84-35DC-48C1-8326-64FE51B00A60Q33540291-81BA99BE-87B5-4E0A-93C7-D522216D9DB3Q34011217-C647FCE6-1D4F-4ACB-B8EE-F2C13E48EEF5Q34432878-A3AB3770-FCFD-448F-A3F2-1BBF6097CF3EQ35968411-FB0A6F95-1200-4C31-B3A7-47617F803EFCQ36301783-3FE1D801-F44F-424D-B703-921323A8AA70Q36486780-79B1EBF7-18FE-4524-B72A-D36655987A68Q36521882-AFB2B298-9E8C-4714-8B07-4CEE698ED8B3Q38021356-58361089-4DBC-48D4-8C4C-284BA0F18C83Q38090432-9E249310-E001-404D-BA3A-9BADCDF43655Q40221719-5FD66DB6-9581-4BD5-BB78-744E9F5E5CB8Q42826814-7418DC70-6807-461F-9825-79FBB75EEF78Q47641202-36E69710-7A97-42B6-8C1E-2AEA01312A49Q48334668-B93B9576-1337-4299-995C-85D12974415FQ54112403-B8B296D9-99B7-4D95-84AA-D6DDB6191AD1
P2860
CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
CL100 expression is down-regul ...... eases its malignant potential.
@ast
CL100 expression is down-regul ...... eases its malignant potential.
@en
CL100 expression is down-regul ...... eases its malignant potential.
@nl
type
label
CL100 expression is down-regul ...... eases its malignant potential.
@ast
CL100 expression is down-regul ...... eases its malignant potential.
@en
CL100 expression is down-regul ...... eases its malignant potential.
@nl
prefLabel
CL100 expression is down-regul ...... eases its malignant potential.
@ast
CL100 expression is down-regul ...... eases its malignant potential.
@en
CL100 expression is down-regul ...... eases its malignant potential.
@nl
P2093
P2860
P4510
P356
P1433
P1476
CL100 expression is down-regul ...... eases its malignant potential.
@en
P2093
Ginger J Gardner
Ichiro Kinoshita
Jane Trepel
Luis M Montuenga
Mark Dayton
Michael J Birrer
Nelly Auersperg
PhuongMai Nguyen
Ramon G Manzano
Silvestre Vicent
P2860
P2888
P304
P356
10.1038/SJ.ONC.1205542
P407
P50
P577
2002-06-01T00:00:00Z
P5875
P6179
1003835804